Jesper Bøje Andersen
Professor
Andersen Group
Ole Maaløes Vej 5
2200 København N.
ORCID: 0000-0003-1760-5244
1 - 2 out of 2Page size: 10
- 2022
- Published
Molecular therapeutic targets for cholangiocarcinoma: Present challenges and future possibilities
Høgdall, Dan Taksony Solyom, O'Rourke, Colm & Andersen, Jesper Bøje, 2022, Advances in Cancer Research. Academic Press, Vol. 156. p. 343-366 (Advances in Cancer Research).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- 2019
- Published
Therapeutic Potential of Pharmacoepigenetics in Cholangiocarcinoma
O'Rourke, Colm, Satriano, L., Oliveira, D. V. N. P., Munoz-Garrido, P. & Andersen, Jesper Bøje, 2019, Pharmacoepigenetics. Academic Press, p. 551-562 12 p.Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
ID: 93714085
Most downloads
-
719
downloads
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles - correction
Research output: Contribution to journal › Comment/debate › Research › peer-review
Published -
574
downloads
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
198
downloads
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published